India · Delayed Price · Currency is INR NSE:QMSMEDI Statistics
Total Valuation
NSE:QMSMEDI has a market cap or net worth of INR 3.05 billion. The enterprise value is 3.83 billion.
| Market Cap | 3.05B |
| Enterprise Value | 3.83B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Sep 23, 2026 |
Share Statistics
NSE:QMSMEDI has 19.34 million shares outstanding. The number of shares has increased by 11.45% in one year.
| Current Share Class | 19.34M |
| Shares Outstanding | 19.34M |
| Shares Change (YoY) | +11.45% |
| Shares Change (QoQ) | -49.31% |
| Owned by Insiders (%) | 68.00% |
| Owned by Institutions (%) | n/a |
| Float | 4.70M |
Valuation Ratios
The trailing PE ratio is 28.94.
| PE Ratio | 28.94 |
| Forward PE | n/a |
| PS Ratio | 1.67 |
| PB Ratio | 2.68 |
| P/TBV Ratio | 4.39 |
| P/FCF Ratio | 22.38 |
| P/OCF Ratio | 15.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.04, with an EV/FCF ratio of 28.06.
| EV / Earnings | 35.29 |
| EV / Sales | 2.09 |
| EV / EBITDA | 14.04 |
| EV / EBIT | 16.53 |
| EV / FCF | 28.06 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.73 |
| Debt / FCF | 5.46 |
| Interest Coverage | 3.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.26% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.68% |
| Revenue Per Employee | 20.59M |
| Profits Per Employee | 1.22M |
| Employee Count | 89 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:QMSMEDI has paid 47.86 million in taxes.
| Income Tax | 47.86M |
| Effective Tax Rate | 27.35% |
Stock Price Statistics
The stock price has increased by +80.60% in the last 52 weeks. The beta is 0.67, so NSE:QMSMEDI's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +80.60% |
| 50-Day Moving Average | 127.84 |
| 200-Day Moving Average | 99.37 |
| Relative Strength Index (RSI) | 65.75 |
| Average Volume (20 Days) | 35,243 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:QMSMEDI had revenue of INR 1.83 billion and earned 108.56 million in profits. Earnings per share was 5.46.
| Revenue | 1.83B |
| Gross Profit | 903.78M |
| Operating Income | 231.76M |
| Pretax Income | 175.01M |
| Net Income | 108.56M |
| EBITDA | 272.89M |
| EBIT | 231.76M |
| Earnings Per Share (EPS) | 5.46 |
Balance Sheet
The company has 66.60 million in cash and 744.81 million in debt, with a net cash position of -678.21 million or -35.07 per share.
| Cash & Cash Equivalents | 66.60M |
| Total Debt | 744.81M |
| Net Cash | -678.21M |
| Net Cash Per Share | -35.07 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 29.67 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 194.37 million and capital expenditures -57.87 million, giving a free cash flow of 136.50 million.
| Operating Cash Flow | 194.37M |
| Capital Expenditures | -57.87M |
| Depreciation & Amortization | 41.13M |
| Net Borrowing | -24.74M |
| Free Cash Flow | 136.50M |
| FCF Per Share | 7.06 |
Margins
Gross margin is 49.32%, with operating and profit margins of 12.65% and 5.92%.
| Gross Margin | 49.32% |
| Operating Margin | 12.65% |
| Pretax Margin | 9.55% |
| Profit Margin | 5.92% |
| EBITDA Margin | 14.89% |
| EBIT Margin | 12.65% |
| FCF Margin | 7.90% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.45% |
| Shareholder Yield | -11.13% |
| Earnings Yield | 3.55% |
| FCF Yield | 4.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |